financetom
Business
financetom
/
Business
/
EU antitrust regulators to rule on Universal, Downtown Music deal by July 22
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
EU antitrust regulators to rule on Universal, Downtown Music deal by July 22
Jun 17, 2025 8:54 AM

BRUSSELS (Reuters) -EU antitrust regulators will decide by July 22 whether to clear Universal Music Group's $775 million acquisition of Downtown Music, according to a European Commission filing on Tuesday.

Virgin Music Group, the global independent music unit of Universal, announced the deal in December last year. World number one music label UMG represents global stars such as Taylor Swift and Billie Eilish.

Downtown Music collectively serves over 5,000 business clients and more than four million creators across 145 countries. Its music publishing unit counts John Lennon & Yoko Ono, George Gershwin, Miles Davis, Wu-Tang Clan and John Prine among its clients.

The EU executive, which acts as the competition enforcer in the 27-country bloc, can clear the deal with or without remedies in its preliminary review or it can open a four-month long investigation if it has serious concerns.

Analysts said a full-scale investigation seems the likeliest option in view of the market power of big music labels.

The deal has triggered criticism from European independent music labels group Impala which said the acquisition would further entrench Universal's position across European music markets and give it more control over streaming services.

Impala, which wants the deal to be blocked, said the acquisition would also reduce opportunities for independent labels.

Universal said it look forward to continuing to co-operate with the European Commission in the weeks ahead.

"We are confident that we will close this acquisition in the second half of the year, on its original timeline," the company said in an email.

A former chief economist at the UK's competition authority in a June 12 letter to EU antitrust chief Teresa Ribera voiced worries about the deal.

The acquisition "represents another step in UMG's broader strategy of undermining the vitality and viability of the independent music sector - both in the EU and globally - with a view to strengthening its own position, and potentially also that of the other two majors (Warners and Sony)", Amelia Fletcher said in her letter seen by Reuters.

Fletcher co-founded a small independent label and publisher which uses Downtown's services.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Kanzhun's Board Approves New $150 Million Share Repurchase Program
Kanzhun's Board Approves New $150 Million Share Repurchase Program
Aug 29, 2024
08:09 AM EDT, 08/29/2024 (MT Newswires) -- Kanzhun ( BZ ) said Thursday that the company's board of directors has authorized a new $150 million share repurchase program, starting Aug. 29 for 12 months. The new program will operate together with the existing $200 million share repurchase program that became effective on Mar. 20 for 12 months, the company said....
Catalent Fiscal Q4 Adjusted Earnings, Net Revenue Climb
Catalent Fiscal Q4 Adjusted Earnings, Net Revenue Climb
Aug 29, 2024
08:08 AM EDT, 08/29/2024 (MT Newswires) -- Catalent ( CTLT ) reported fiscal Q4 adjusted earnings Thursday of $0.65 per diluted share, up from $0.02 a year earlier. Analysts polled by Capital IQ expected $0.56. Net revenue for the quarter ended June 30 was $1.3 billion, up from $1.06 billion a year earlier. Analysts polled by Capital IQ expected $1.24...
XORTX Surges 62% in U.S. Premarket as Peer-Reviewed Research Backs Company's Approach to Polycystic Kidney Disease
XORTX Surges 62% in U.S. Premarket as Peer-Reviewed Research Backs Company's Approach to Polycystic Kidney Disease
Aug 29, 2024
08:09 AM EDT, 08/29/2024 (MT Newswires) -- XORTX Therapeutics ( XRTX ) jumped 62% on Thursday in New York premarket trading after the company said that recent peer-reviewed, independent, published research shows genetic factors are linked to the over-expression of xanthine oxidase (XO) and play a role in several diseases, including kidney disease. The findings support the company's approach to...
Umb Financial Insider Sold Shares Worth $735,162, According to a Recent SEC Filing
Umb Financial Insider Sold Shares Worth $735,162, According to a Recent SEC Filing
Aug 29, 2024
04:14 PM EDT, 08/27/2024 (MT Newswires) -- James D Rine, President, on Aug. 23, sold 7,315 shares in Umb Financial ( UMBF ) for $735,162. Following the Form 4 filing with the SEC, Rine has control over a total of 46,339 shares of the company, with 44,917 shares held directly and 1,422 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/101382/000112760224022963/xslF345X05/form4.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved